NRXS
Price
$7.01
Change
-$0.15 (-2.09%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
86.69M
86 days until earnings call
Intraday BUY SELL Signals
PVLA
Price
$118.44
Change
-$0.40 (-0.34%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.7B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXS vs PVLA

NRXS vs PVLA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRXS vs. PVLA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Buy and PVLA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (NRXS: $7.16 vs. PVLA: $118.84)
Brand notoriety: NRXS and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 41% vs. PVLA: 97%
Market capitalization -- NRXS: $88.67M vs. PVLA: $1.7B
NRXS [@Biotechnology] is valued at $88.67M. PVLA’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 4 TA indicator(s) are bullish while PVLA’s TA Score has 4 bullish TA indicator(s).

  • NRXS’s TA Score: 4 bullish, 5 bearish.
  • PVLA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than NRXS.

Price Growth

NRXS (@Biotechnology) experienced а +5.29% price change this week, while PVLA (@Biotechnology) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

NRXS is expected to report earnings on Sep 17, 2026.

PVLA is expected to report earnings on Aug 13, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($1.7B) has a higher market cap than NRXS($86.7M). NRXS YTD gains are higher at: 57.709 vs. PVLA (13.538). NRXS has higher annual earnings (EBITDA): -7.12M vs. PVLA (-42.66M). PVLA has more cash in the bank: 262M vs. NRXS (7.08M). NRXS has less debt than PVLA: NRXS (354K) vs PVLA (584K). NRXS has higher revenues than PVLA: NRXS (4.28M) vs PVLA (0).
NRXSPVLANRXS / PVLA
Capitalization86.7M1.7B5%
EBITDA-7.12M-42.66M17%
Gain YTD57.70913.538426%
P/E RatioN/A14.22-
Revenue4.28M0-
Total Cash7.08M262M3%
Total Debt354K584K61%
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXSPVLA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signal:
Gain/Loss:
PVLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LNGX40.750.82
+2.06%
Global X U.S. Natural Gas ETF
ZAPR26.59-0.01
-0.04%
Innovator Equity Dfnd Prt ETF -1 Yr Apr
FOCT52.15-0.08
-0.15%
FT Vest US Equity Buffer ETF Oct
NPV11.38-0.03
-0.26%
Nuveen Virginia Quality Municipal Income Fund
CUT27.80-0.17
-0.62%
Invesco MSCI Global Timber ETF

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+0.14%
CVM - NRXS
58%
Loosely correlated
-2.88%
ANRO - NRXS
27%
Poorly correlated
+0.84%
PVLA - NRXS
26%
Poorly correlated
+5.08%
OMER - NRXS
25%
Poorly correlated
+0.44%
CTMX - NRXS
25%
Poorly correlated
+2.88%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+5.08%
DRMA - PVLA
42%
Loosely correlated
+5.13%
VIR - PVLA
41%
Loosely correlated
+4.48%
IOVA - PVLA
38%
Loosely correlated
+3.84%
ARQT - PVLA
37%
Loosely correlated
+1.76%
SEPN - PVLA
35%
Loosely correlated
-3.70%
More